<DOC>
	<DOC>NCT00258882</DOC>
	<brief_summary>To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.</brief_summary>
	<brief_title>Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACELâ„¢ Vaccine</brief_title>
	<detailed_description>Surveillance using a healthcare organization with large comprehensive medical encounter databases will be used in this study to identify any risks or uncommon events associated with use of the recently licensed Adacel vaccine that may occur in routine clinical usage in a large population. No investigational vaccines will be administered in this study. Participants will be included in the study on the basis of their having received Adacel vaccine as part of routine care.</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<criteria>Receipt of ADACEL vaccine during the study period</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Tetanus Toxoid,</keyword>
	<keyword>acellular pertussis,</keyword>
	<keyword>diphtheria toxoid</keyword>
</DOC>